DNA And Gene Chip Market Report 2026

DNA And Gene Chip Market Overview

• DNA And Gene Chip market size has reached to $9.2 billion in 2025 • Expected to grow to $16.99 billion in 2030 at a compound annual growth rate (CAGR) of 12.9% • Growth Driver: Early Cancer Detection Driving Growth Of DNA And Gene Chip Market • Market Trend: Groundbreaking Genotyping Chip To Advance The Food Industry And Democratize Insect Consumption • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under DNA And Gene Chip Market?

A DNA and gene chip is a microchip that contains microscopic DNA probes attached to a solid surface that can identify DNA from test samples and make up half of the DNA double helix. If the test sample of DNA has the mutation, then the DNA will not bind properly to the sequence on the chip. The DNA and gene chip is used to measure the expression levels of genes or to ascertain whether a particular person's DNA has mutations in genes which are variations in DNA which can cause ailments. The main types of DNA and gene chips are oligonucleotide DNA (O-DNA), complementary DNA (C-DNA), and other types. Oligonucleotide DNA is short single- or double-stranded DNA or RNA fragments containing three to twenty nucleotides. Several products involved are consumables and instruments. It is used in various applications such as cancer diagnostics, gene expression, proteomics, genomics, drug discovery, agrigenomics, and others. The various end-user industries are involved such as academic and government research institutes, biotechnology and pharmaceutical companies, hospitals and diagnostics centers, and others.

What Is The DNA And Gene Chip Market Growth Forecast?

The dna and gene chip market size is expected to see rapid growth in the next few years. It will grow to $16.99 billion in 2030 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to increasing focus on personalized medicine, rising investments in genomics-based drug discovery, expansion of population-scale genetic screening, growing adoption of ai-driven genomic analytics, increasing use of gene chips in agrigenomics. Major trends in the forecast period include increasing adoption of high-density gene expression arrays, rising use of single-cell analysis chips, growing demand for precision oncology diagnostics, expansion of snp and whole genome analysis chips, enhanced focus on high-throughput genomic screening.

Global DNA And Gene Chip Market Segmentation

1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA) 2) By Application: Cancer Diagnostics, Gene Expression, Genomics, Drug Discovery, Agrigenomics 3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users Subsegments: 1) By Oligonucleotide DNA (o-DNA): Custom Oligonucleotide Chips, Commercial Oligonucleotide Arrays 2) By Complementary DNA (c-DNA): cDNA Microarrays, cDNA Expression Arrays

What Is The Driver Of The DNA And Gene Chip Market?

The rising demand for early cancer detection is significantly contributing to the growth of the DNA and gene market. Cancer is a broad class of conditions that can develop in practically any organ or tissue of the body when aberrant cells multiply uncontrollably, cross normal cell boundaries to invade nearby organs, and spread to other regions of the body. Rising demand for early cancer detection is increasing because growing awareness about the benefits of identifying cancer at an initial stage is leading people to seek timely screening, which improves treatment outcomes and survival chances. DNA and gene chips are used to measure gene expression patterns, determine the genetic and epigenetic landscape, and measure genomic regulatory elements bound by cancer transcription factors in cancerous cells. For instance, in May 2025, according to a report published by the National Cancer Institute (NCI), a US-based federal government agency, in 2025, the United States is expected to see about 2,041,910 new cancer cases and approximately 618,120 deaths from the disease. Therefore, rising demand for early cancer detection is driving the growth of the DNA and gene chip industry.

Key Players In The Global DNA And Gene Chip Market

Major companies operating in the dna and gene chip market are Illumina Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., CapitalBio Corporation, Microarrays Inc., Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Bioneer Corporation, QIAGEN N.V., Bio-Rad Laboratories Inc., BioChain Institute Inc., Fluidigm Corporation, LC Sciences, Macrogen Inc., Greiner Bio-One International GmbH, F. Hoffmann-La Roche Ltd, GE Healthcare, Hitachi High-Technologies Corporation

Global DNA And Gene Chip Market Trends and Insights

Major companies operating in the DNA and gene chip market are developing groundbreaking genotyping chips such as Axiom YNS_Mol1 to advance the food industry and democratize insect consumption. Axiom YNS_Mol1 is the genotyping chip designed specifically for insect breeding, notably the Tenebrio Molitor mealworm. For instance, in June 2023, Ÿnsect, a France-based company specializing in insect production, unveiled the World's first genotyping chip for insect breeding, Axiom YNS_Mol1. It is a groundbreaking genotyping chip designed in partnership with Thermo Fisher Scientific, aiming to revolutionize insect breeding for sustainable food and pet food. The chip analyzes genetic characteristics, promoting genomic diversity and improving traits like growth, reproduction, and disease resistance in Tenebrio Molitor mealworms. This innovative step is part of Ÿnsect'sŸnFABRE project, contributing to the advancement of entomoculture and sustainable solutions in response to environmental challenges.

What Are Latest Mergers And Acquisitions In The DNA And Gene Chip Market?

In December 2024, Hendrix Genetics, a Netherlands-based animal breeding technology company, partnered with LABOGENA DNA to secure exclusive high-throughput genotyping services for its multi species breeding program. With this partnership, Hendrix Genetics aims to enhance and accelerate its genotyping capabilities to drive improved genetic gain across its multi-species breeding programs through exclusive access to LABOGENA DNA’s high-throughput genotyping services. LABOGENA DNA is a France-based industrial genotyping and sequencing company that specializes in high-throughput SNP-chip genotyping, targeted sequencing, DNA extraction, custom SNP matrices and R&D consulting from its ISO 17025-accredited laboratory near Paris.

Regional Outlook

North America was the largest region in the DNA and gene chip market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the DNA And Gene Chip Market?

The DNA and gene chip market consists of sales of instrumentation and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.